翰思艾泰生物医药科技（武汉）股份有限公司（股票简称：翰思艾泰-B，代码：03378）于2026年4月22日公告称，公司当日于香港联交所场内回购31,200股股份，约占已发行股本的0.0229%。每股回购价介乎31.18港元至31.98港元，合计耗资988,500港元，折合约98.85万港元。
本次回购完成后，公司已发行股本总数为136,218,830股，其中包括135,941,630股已发行股份及277,200股库存股份。购回授权由股东于2026年2月12日通过，可回购股份总数为13,621,883股，目前累计已回购277,200股，约占授权通过时已发行股本总数的0.2035%。
公司确认已遵守香港联交所上市规则及所有相关法律法规。本公告由公司董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.